Owners, management and financials
CVR: 27347177
Previous names: ORIFARM HOLDING A/S
DKK -446,000
Gross profit
Net result: DKK 298,665,000
ORIFARM GROUP A/S (100%)
CVR · view owners
Thomas Brandhof
Board: Hans Carl Bøgh-Sørensen (chair) and 2 members
CVR · view management
Active
Founded 12 September 2003
CVR · view overview
0 employees
CVR · 2018
Director role ended: Erik Sandberg
CVR · 01/02/2019
View the full event history
ORIFARM PI A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Finansielle holdingselskaber. The company was previously named ORIFARM HOLDING A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM GROUP A/S. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK -446,000 and a net result of DKK 298,665,000 compared with DKK 320,939,000 the year before. Equity in the 2025 report amounted to DKK 1,391,995,000.
Selskabets formål er at besidde aktierne i Orifarm selskaberne samt at erhverve og besidde immaterielle og materielle aktiver, som knytter sig til disse selskaber.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -446 t. | 298.7 mio. | 1.6 mia. | 1.4 mia. | 0 | |
| 202401/01/2024 – 31/12/2024 | -58 t. | 320.9 mio. | 1.3 mia. | 1.2 mia. | 0 | |
| 202301/01/2023 – 31/12/2023 | -95 t. | 253.4 mio. | 1.1 mia. | 940.7 mio. | - | |
| 202201/01/2022 – 31/12/2022 | -73 t. | 182.9 mio. | 817.8 mio. | 687.4 mio. | 0 | |
| 202101/01/2021 – 31/12/2021 | -76 t. | 206 mio. | 857.7 mio. | 760 mio. | 0 | |
| 202001/01/2020 – 31/12/2020 | -57 t. | 208.7 mio. | 659.1 mio. | 563.8 mio. | 0 | |
| 201901/01/2019 – 31/12/2019 | -71 t. | 191.8 mio. | 554.4 mio. | 554.4 mio. | - | |
| 201801/01/2018 – 31/12/2018 | -169 t. | 149 mio. | 560.7 mio. | 502.6 mio. | - | |
| 201701/01/2017 – 31/12/2017 | -174 t. | 99.7 mio. | 444.8 mio. | 357.5 mio. | - | |
| 201601/01/2016 – 31/12/2016 | -203 t. | 50.1 mio. | 383.7 mio. | 256.8 mio. | - | |
| 201501/01/2015 – 31/12/2015 | -27 t. | 25.3 mio. | 331.2 mio. | 206.2 mio. | - | |
| 201401/01/2014 – 31/12/2014 | -30 t. | 18.7 mio. | 150.4 mio. | 59 mio. | - | |
| 201301/01/2013 – 31/12/2013 | -30 t. | 18.5 mio. | 65.7 mio. | 42.6 mio. | - | |
| 201201/01/2012 – 31/12/2012 | -46 t. | 17.6 mio. | 48.2 mio. | 25.6 mio. | - |
Compared to 5.694 companies in Finansielle holdingselskaber
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreThe CVR number of ORIFARM PI A/S is 27347177.
ORIFARM PI A/S is owned by ORIFARM GROUP A/S.
The management of ORIFARM PI A/S consists of Thomas Brandhof.
The board of ORIFARM PI A/S consists of Hans Carl Bøgh-Sørensen, Mads Fink Eriksen and Nicki Lund Kristensen, with Hans Carl Bøgh-Sørensen as chair.
In 2025, ORIFARM PI A/S reported a gross profit of DKK -446,000.
ORIFARM PI A/S had 0 employees in 2018 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 63852500 (June 3, 2026).
Contact info changed: new phone: 63852500 (June 2, 2026).
As of June 2, 2026, Hans Carl Bøgh-Sørensen has joined the board of directors of ORIFARM PI A/S.
As of June 2, 2026, Ole Michael Friis has left the board of directors of ORIFARM PI A/S.
As of June 2, 2026, Birgitte Bøgh-Sørensen has left the board of directors of ORIFARM PI A/S.
ORIFARM PI A/S has published its annual report for 2025. Gross profit came to DKK -446,000, and the net result was DKK 298,665,000.
As of June 1, 2026, Hans Carl Bøgh-Sørensen has left the board of directors of ORIFARM PI A/S.
As of October 20, 2025, Nicki Lund Kristensen has joined the board of directors of ORIFARM PI A/S.
ORIFARM PI A/S has published its annual report for 2024. Gross profit came to DKK -58,000, and the net result was DKK 320,939,000.
As of March 17, 2025, Mads Fink Eriksen has joined the board of directors of ORIFARM PI A/S.
As of March 17, 2025, Erik Sandberg has left the board of directors of ORIFARM PI A/S.
ORIFARM PI A/S has published its annual report for 2023. Gross profit came to DKK -95,000, and the net result was DKK 253,407,000.
ORIFARM PI A/S has published its annual report for 2022. Gross profit came to DKK -73,000, and the net result was DKK 182,945,000.
ORIFARM PI A/S has published its annual report for 2021. Gross profit came to DKK -76,000, and the net result was DKK 206,026,000.
ORIFARM PI A/S has published its annual report for 2020. Gross profit came to DKK -57,000, and the net result was DKK 208,734,000.
ORIFARM PI A/S has published its annual report for 2019. Gross profit came to DKK -71,000, and the net result was DKK 191,779,000.
ORIFARM PI A/S has published its annual report for 2018. Gross profit came to DKK -169,000, and the net result was DKK 148,979,000.
As of February 1, 2019, Erik Sandberg has joined the board of directors of ORIFARM PI A/S.
As of February 1, 2019, Thomas Brandhof is registered as adm. dir. of ORIFARM PI A/S.
As of February 1, 2019, Erik Sandberg has stepped down as adm. dir. of ORIFARM PI A/S.
As of June 15, 2018, Claus Christian Bayer has left the board of directors of ORIFARM PI A/S.
ORIFARM PI A/S has published its annual report for 2017. Gross profit came to DKK -174,000, and the net result was DKK 99,654,000.
ORIFARM PI A/S has published its annual report for 2016. Gross profit came to DKK -203,000, and the net result was DKK 50,075,000.
ORIFARM PI A/S has published its annual report for 2015. Gross profit came to DKK -27,000, and the net result was DKK 25,311,000.
ORIFARM PI A/S has published its annual report for 2014. Gross profit came to DKK -30,000, and the net result was DKK 18,740,000.
ORIFARM PI A/S has published its annual report for 2013. Gross profit came to DKK -30,000, and the net result was DKK 18,511,000.
As of May 13, 2014, Birgitte Bøgh-Sørensen has joined the board of directors of ORIFARM PI A/S.
As of May 13, 2014, Erik Sandberg is registered as adm. dir. of ORIFARM PI A/S.
As of May 13, 2014, Hans Carl Bøgh-Sørensen has stepped down as adm. dir. of ORIFARM PI A/S.
On May 13, 2014, the company changed its name from ORIFARM HOLDING A/S to ORIFARM PI A/S.
ORIFARM PI A/S has published its annual report for 2012. Gross profit came to DKK -46,000, and the net result was DKK 17,551,000.
As of October 13, 2011, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of ORIFARM PI A/S.
As of October 13, 2011, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has stepped down as auditor of ORIFARM PI A/S.
As of May 23, 2007, Claus Christian Bayer has joined the board of directors of ORIFARM PI A/S.
As of May 23, 2007, Niels Harald de Coninck-Smith has left the board of directors of ORIFARM PI A/S.
As of May 23, 2006, Niels Harald de Coninck-Smith has joined the board of directors of ORIFARM PI A/S.
As of May 23, 2006, Jan Johannes Wøidemann has left the board of directors of ORIFARM PI A/S.
As of December 31, 2003, ORIFARM GROUP A/S is registered as an owner of ORIFARM PI A/S with an ownership share of 100%.
As of September 12, 2003, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has been appointed auditor of ORIFARM PI A/S.
As of September 12, 2003, Ole Michael Friis has joined the board of directors of ORIFARM PI A/S.
As of September 12, 2003, Jan Johannes Wøidemann has joined the board of directors of ORIFARM PI A/S.
As of September 12, 2003, Hans Carl Bøgh-Sørensen has joined the board of directors of ORIFARM PI A/S.
As of September 12, 2003, Hans Carl Bøgh-Sørensen is registered as adm. dir. of ORIFARM PI A/S.
ORIFARM PI A/S was founded on September 12, 2003.
Companies in the same industry and area
CVR 38767534
CVR 45086259
CVR 34052530
CVR 29778604
CVR 40044302
